Back
Legend Biotech Corp. Vs. Bowman Consulting Group Ltd. Industry Stock Comparison
Sell
43
LEGN
Legend Biotech Corp.
Last Price:
$19.13
Seasonality Move:
24.08%
Sell
44
BWMN
Bowman Consulting Group Ltd.
Last Price:
$29.63
Seasonality Move:
1.39%
Sell
43
Legend Biotech Corp. (LEGN)
is a Sell
Is Legend Biotech Corp. a Buy, Sell or Hold?
-
The current Legend Biotech Corp. [LEGN] share price is $19.14. The Score for LEGN is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
LEGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Bowman Consulting Group Ltd. (BWMN)
is a Sell
Is Bowman Consulting Group Ltd. a Buy, Sell or Hold?
-
The current Bowman Consulting Group Ltd. [BWMN] share price is $29.65. The Score for BWMN is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
BWMN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LEGN Stock Price Chart
What is Legend Biotech Corp.'s stock price today?
-
The Legend Biotech Corp. share price today is $19.14The current trend is relatively stagnant and LEGN is experiencing slight buying pressure.
BWMN Stock Price Chart
What is Bowman Consulting Group Ltd.'s stock price today?
-
The Bowman Consulting Group Ltd. share price today is $29.65The current trend is relatively stagnant and BWMN is experiencing buying pressure, which is a positive indicator for future bullish movement.
LEGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.16 | Sell |
| Relative Strength Index (14 RSI): | 56.72 | Buy |
| Chaikin Money Flow: | 386687 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.44 - 19.16) | Buy |
| Bollinger Bands (100): | (17.38 - 25.88) | Sell |
BWMN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.73 | Sell |
| Relative Strength Index (14 RSI): | 49.61 | Sell |
| Chaikin Money Flow: | 51978 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.4 - 31.18) | Buy |
| Bollinger Bands (100): | (30.57 - 35.89) | Sell |
LEGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.82 | Buy |
| 20-day SMA: | 18.33 | Buy |
| 50-day SMA: | 18.22 | Buy |
| 200-day SMA: | 28.53 | Sell |
| 8-day EMA: | 18.2 | Buy |
| 20-day EMA: | 18.19 | Buy |
| 50-day EMA: | 19.13 | Buy |
| 200-day EMA: | 26.29 | Sell |
BWMN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.98 | Buy |
| 20-day SMA: | 28.55 | Buy |
| 50-day SMA: | 31.74 | Sell |
| 200-day SMA: | 35.62 | Sell |
| 8-day EMA: | 28.94 | Buy |
| 20-day EMA: | 29.27 | Buy |
| 50-day EMA: | 31.11 | Sell |
| 200-day EMA: | 33.16 | Sell |
Legend Biotech Corp. Earnings Growth & LEGN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.33 per share, an increase next quarter of $0.11 per share, an increase this year of $1.66 per share, and an increase next year of $1.09 per share.
Bowman Consulting Group Ltd. Earnings Growth & BWMN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.11 per share, an increase this year of $0.09 per share, and an increase next year of $0.56 per share.
Legend Biotech Corp. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bowman Consulting Group Ltd. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||